AFNIX
Price
$25.93
Change
+$0.14 (+0.54%)
Updated
Jul 3 closing price
Net Assets
1.85B
VIVIX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

AFNIX vs VIVIX

Header iconAFNIX vs VIVIX Comparison
Open Charts AFNIX vs VIVIXBanner chart's image
Bahl & Gaynor Income Growth I
Price$25.93
Change+$0.14 (+0.54%)
VolumeN/A
Net Assets1.85B
Vanguard Value Index I
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
AFNIX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AFNIX vs. VIVIX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFNIX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 189B vs. AFNIX (1.85B). VIVIX pays higher dividends than AFNIX: VIVIX (2.19) vs AFNIX (1.87). AFNIX was incepted earlier than VIVIX: AFNIX (13 years) vs VIVIX (27 years). AFNIX (0.60) is less costly to investors than VIVIX (0.04). AFNIX is a more actively managed with annual turnover of: 12.00 vs. VIVIX (9.00). AFNIX has a lower initial minimum investment than VIVIX: AFNIX (25000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 11.41 vs. AFNIX (5.32). VIVIX return over 5 years is better than : 79.11 vs. AFNIX (57.94).
AFNIXVIVIXAFNIX / VIVIX
Total Expense Ratio0.600.041,500%
Annual Report Gross Expense Ratio0.600.041,500%
Fund Existence13 years27 years-
Gain YTD4.8365.60986%
Front LoadN/AN/A-
Min. Initial Investment2500050000001%
Min. Initial Investment IRAN/AN/A-
Net Assets1.85B189B1%
Annual Yield % from dividends1.872.1985%
Returns for 1 year5.3211.4147%
Returns for 3 years24.5434.4071%
Returns for 5 years57.9479.1173%
Returns for 10 years131.99114.45115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KB85.701.60
+1.90%
KB Financial Group
BNL16.340.14
+0.86%
Broadstone Net Lease
EYPT9.720.06
+0.62%
EyePoint Pharmaceuticals
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc